Suhovskih et al. [14] reported that in prostate tumors, complex changes occur in PGs, with decreased expression of decorin and lumican, an overall increase in syndecan-1 and glypican-1 in tumor stroma, along with the disappearance of agrecan in tumor epithelial cells. The gene discussed is LUM; the disease is neoplasm.